Login / Signup

Safety and Efficacy of Eluxadoline in Patients with Irritable Bowel Syndrome-Diarrhea With or Without Bile Acid Diarrhea: Open-Label Study.

Priya VijayvargiyaMargaret Breen-LylesSara Linker NordDaniel MaselliIrene BusciglioRamesh BoinpallyAnna MuslinTimothy J CarrothersMichael Camilleri
Published in: Digestive diseases and sciences (2022)
Eluxadoline is similarly efficacious in the treatment of IBS-D and BAD, and it appears to be safe and efficacious as documented in large clinical trials.
Keyphrases
  • irritable bowel syndrome
  • clinical trial
  • open label
  • phase ii
  • phase iii
  • squamous cell carcinoma
  • randomized controlled trial
  • combination therapy
  • double blind
  • smoking cessation